CC
IRWD icon

Carlson Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Carlson Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-865,650
Closed -$11.1M – 287
2016
Q4 		$11.1M Buy
+865,650
New +$10.9M 0.13% 178
2016
Q3 		– Sell
-1,313,400
Closed -$14.4M – 288
2016
Q2 		$14.4M Buy
+1,313,400
New +$12.8M 0.18% 164

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carlson Capital's IRWD Position: Q1 2017 in Review

Carlson Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2017, closing a stake of 865,650 shares — an estimated $11.1M sold.

Carlson Capital first reported a position in IRWD in Q2 2016 and held it in 2 quarters. The position peaked at $14.4M in Q2 2016. 162 funds tracked by Wall St. Rank hold IRWD as of Q1 2017.

  • Carlson Capital reported no remaining Ironwood Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Carlson Capital sold 865,650 Ironwood Pharmaceuticals shares in Q1 2017, an estimated $11.1M.
  • Carlson Capital first reported a position in Ironwood Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Carlson Capital's Ironwood Pharmaceuticals position peaked at $14.4M in Q2 2016.
  • 162 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2017.

Based on Carlson Capital's 13F filing for Q1 2017, filed 15 May 2017.